Old Web
English
Sign In
Acemap
>
Paper
>
1172MO Durvalumab consolidation in patients with stage III non-resecable NSCLC with driver genomic alterations
1172MO Durvalumab consolidation in patients with stage III non-resecable NSCLC with driver genomic alterations
2021
M. Riudavets Melia
Edouard Auclin
M.A. Mosteiro Lamas
N. Dempsey
Margarita Majem
R. Lobefaro
R. López-Castro
J. Bosch Barrera
Sara Pilotto
E. Escalera Martín
M. Tagliamento
J Mosquera Martínez
G. Zalcman
E. Nadal
Graça Videira Lopes
Diego Signorelli
M. R. Garcia-Campelo
B Besse
David Planchard
L Mezquita
Keywords:
Consolidation (soil)
Durvalumab
in patient
Oncology
Internal medicine
Stage (cooking)
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]